NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets
PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Regulatory News: NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company[…]
Read more